macrofilaricidal compounds (Anacor Pharmaceuticals/Sandler center for drug discovery)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemacrofilaricidal compounds (Anacor Pharmaceuticals/Sandler center for drug discovery)
Drug Alias Nameantiparasitic compounds (Anacor Pharmaceuticals/Sandler center for drug discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOnchocerciasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSandler Center for Drug DiscoveryAnacor Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOnchocerciasis

Other Information

ATC CodeN/A
Related LinksN/A